Defense World
15 Nov 2025, 08:44 UTC · 44w ago
Verdict
Headline takes no side. We score ZURA +0.60 across two claims — strongly bullish.
+0.60strongly bullish
More positive than 73% of ticker scores this week
What the story claims
2 claims · scored −1 bearish … +1 bullish
Zura Bio Limited has an average analyst rating of "Moderate Buy" based on six ratings firms.
So whatGeneral positive sentiment from the majority of covering analysts typically supports a higher valuation for small-cap biotech stocks.
More positive than 63% of claims this week
Four out of six analysts covering ZURA have assigned a 'buy' rating.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
More positive than 50% of claims this week
Which stocks this story touches
More positive than 73% of ticker scores this week
The company has a 'Moderate Buy' average rating with a majority of analysts assigning a buy rating.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Newsfile Corp
1h ago
+6.1%
Price agrees with the score
$4.33 vs $4.08 close before publication (Nov 14) · not market-adjusted
ZURA chart →
